The additional benefit of the ML Flow test to classify leprosy patients.

The additional benefit of the ML Flow test to classify leprosy patients.

Item
http://www.wikidata.org/entity/Q38928072
Integrative literature review of the reported uses of serological tests in leprosy managementImmunologically reactive M. leprae antigens with relevance to diagnosis and vaccine developmentDiagnostic challenges of single plaque-like lesion paucibacillary leprosy.Mycobacterium leprae-host-cell interactions and genetic determinants in leprosy: an overview.Comparison of two rapid tests for anti-phenolic glycolipid-I serology in Brazil and Nepal.The potential for vaccination in leprosy elimination: new tools for targeted interventions.Utility of immunoglobulin isotypes against LID-1 and NDO-LID for, particularly IgG1, confirming the diagnosis of multibacillary leprosy.Mycobacterium leprae-Specific Antibodies in Multibacillary Leprosy Patients Decrease During and After Treatment With Either the Regular 12 Doses Multidrug Therapy (MDT) or the Uniform 6 Doses MDT.
P2860

The additional benefit of the ML Flow test to classify leprosy patients.

Item
http://www.wikidata.org/entity/Q38928072
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
The additional benefit of the ML Flow test to classify leprosy patients.
@en
type
label
The additional benefit of the ML Flow test to classify leprosy patients.
@en
prefLabel
The additional benefit of the ML Flow test to classify leprosy patients.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
The additional benefit of the ML Flow test to classify leprosy patients.
@en
P2093
P304
P31
P356
10.1016/J.ACTATROPICA.2009.04.009
P433
P478
P50
P577
P698
P921